Back to top

Pediatric Cancer Center Barcelona

A comprehensive center by all and for all for the benefit of children and adolescents with cancer


The SJD Barcelona Children's Hospital Pediatric Cancer Center Barcelona, about to become a reality in 2022

The Pediatric Cancer Center Barcelona is a new monographic center for the benefit of children and adolescents with cancer and their families. The facility will bring together the healthcare services aimed at patients with developmental cancer in one single place, as well as spaces dedicated to research. The aim is to treat a large volume of patients more effectively, efficiently and adequately, more than 400 new patients per year, with the highly specialised team of the SJD Barcelona Children's Hospital Oncology Department.

The Pediatric Cancer Center Barcelona aims to establish itself as a leading international development cancer center.

Objectives of the Pediatric Cancer Center Barcelona

To continue increasing the capacity to cure childhood cancer by offering comprehensive and personalised care

To obtain new effective treatments for currently incurable cancers

To reduce the sequelae of surviving children

To be a center open to the world and with a vocation for service

Our specialisms

We focus our experience on six clinical areas aimed at different types of patients, to ensure the best medical care, always seeking the best possible experience. The SJD Barcelona Children's Hospital Pediatric Cancer Center Barcelona will offer multidisciplinary, super-specialised, highly complex and comprehensive care.

In the case of solid tumours in pediatric patients, we have a Molecular Oncology Laboratory specialising in the genetic characterisation of these tumours, which allows us to offer patients a more personalised and appropriate treatment based on the genetic abnormalities of their tumour.


We treat central nervous system tumours such as medulloblastoma and other embryonal tumours, high- and low-grade and diffuse K27M mutated midline gliomas, ependymoma, craniopharyngioma, germ cell tumour, and choroid plexus tumour.

It is not covered by public health

Extracranial solid tumours

Experts in pathologies such as neuroblastoma, retinoblastoma, osteosarcoma, Ewing's sarcoma, rhabdomyosarcoma, Wilms tumour, nephroblastoma, vascular tumour (hemangioma, venous and arterial malformation), hepatoblastoma and germ cell tumour.

It is not covered by public health

Tumours of the hematopoietic system

Leukemias, lymphomas (non-Hodgkin and Hodgkin), histiocytosis and congenital spinal cord failure are the focus of our healthcare activity in this field.

It is not covered by public health

Hematopoietic stem cell transplant

We have a bone marrow transplantation unit with all the technical and human means required to perform the entire transplant process.

Cancer predisposition

We are specialists in hereditary cancer syndromes, such as neurocutaneous diseases (neurofibromatosis 1 and 2), tuberous sclerosis or syndromes such as Li-Fraumeni, among others.

It is not covered by public health

Cancer survivor follow-up

Care for cancer patients does not end with the treatment. We provide the support and services necessary to make going back to school, family and friends a positive experience.

It is not covered by public health

Precision diagnosis

We have innovative diagnostic techniques that allow us to identify therapeutic targets and offer personalised therapies.

  • Molecular diagnosis: We have a Molecular Oncology Laboratory specialising in the genetic characterisation of solid tumours which allows us to offer patients a more personalised and appropriate treatment based on the genetic abnormalities of their tumour.
  • Diagnostic imaging: Our Diagnostic Imaging Service  is specialised in the study of paediatric oncological imaging biomarkers that enable us to have non-invasive anatomical, metabolic and functional  information, thus increasing the precision of the initial diagnosis while also establishing patient prognosis and follow-up. We also have intraoperative magnetic resonance imaging in our surgical block that allows us to improve surgical precision and safety.
  • Nuclear medicine:  This allows us to perform very important diagnostic tests in a set of paediatric oncological diseases. It is applied for the detection and determination of the extent of the disease, for monitoring or for the detection of relapses. Moreover, not only is it useful for diagnostic purposes, but it is also useful in the treatment of certain solid tumours.

Advanced therapies

We have a high capability to develop advanced therapies in childhood oncology which are available in very few centers worldwide.

Innovative research and methods

The Developmental Cancer Research Laboratory, integrated into the Pediatric Cancer Center Barcelona facilities, was inaugurated in 2003 and has built up nearly 20 years of experience in translational research, which is research that seeks answers to the needs of our patients. Our goal is for advances in research to be translated into new treatments and applied to patient care.

More than 50 professionals, including researchers and technicians, work in this laboratory, which contains a bank of pediatric tumours of high value for research and experimentation. In the laboratory, molecular techniques and genomic technology are also applied, which allow the analysis of the gene expression of tumours and open new options in the fields of patient diagnosis and prognosis.

With a research team which is fully integrated with the healthcare team, our cutting-edge research, clinical trials and treatments allow our specialists to provide the safest and most effective care possible.

What characterises our research

Pre-clinical models

Patient samples are processed in the laboratory to evaluate the efficacy and safety of new treatments, before the clinical phase.

Pediatric tumour bank

This is a key piece in our research, since the study of patients' tumours is the first step to achieving results.

Clinical Trials Unit

We have the first Clinical Trials Unit in Spain that centers on paediatrics, with a substantial volume of patients and trials.


The oncology training that we offer is one of the Pediatric Cancer Center Barcelona's strategic tools. Our objective is to optimise the scientific and personal development of the professionals who care for children and adolescents with cancer.

  • Seminars and courses: We offer continuing education courses in cancer for physicians, nurses and other healthcare professionals.
  • Pre-graduate training: We are involved with the pre-graduate training of medical students from the Universitat de Barcelona and with nursing students.
  • Post-graduate training: Our team oversees oncology training for paediatric and paediatric nursing residents.
  • Paediatric oncology grant programme: the paediatric cancer and development grant programme is well consolidated and is our country's oldest. The programme runs for three years, in the course of which the research assistants are trained in the different clinical and research aspects of our sub-speciality.
  • Online telematic initiatives: Online training has made it possible to move continuing education to platforms such as TELEO (Tele-education in Paediatric Oncology), which was created to support and bolster local training programmes for specialists in Latin America, particularly in medium-to-low income countries in which such training was hitherto impossible.

The dimensions of the Pediatric Cancer Center Barcelona

The center has the capacity to receive 400 new patients each year; it ranks as the fourth center worldwide for developmental cancer patient care.

Surface area
Research space
Space for healthcare
Transplant chambers
Boxes in the Day Hospital
Outpatient consultation rooms

Families and professionals united to achieve the best Pediatric Cancer Center Barcelona

Without the involvement of our professionals, our patients and their families, the Pediatric Cancer Center Barcelona could not become a reality in 2022.

With the collaboration of more than 80 patients and families who have gone through the experience of childhood cancer and more than 30 professionals from the SJD Barcelona Children's Hospital, we have designed what the spaces, the setting, the necessary technology and the medical and emotional care should look like, working in co-creation sessions and testing the suitability of the facilities.

An international center, open to the world and with a service vocation

We receive requests from many countries to treat children with developmental cancer. In 2020, a year marked by a global pandemic, we received more than 880 requests from 80 countries. To these patients, we must add those we treat collectively thanks to the PCCB Charity Fund programme.

In addition, our professionals are involved in improving diagnosis and treatment, for which they are leaders in the training of medical professionals, especially in the American continent. They are also part of international teams conducting clinical trials.

Pediatric Cancer Center Barcelona in solidarity with everyone

And we cannot forget that the Pediatric Cancer Center Barcelona will become a reality thanks to the support of all the people, companies and institutions that help us financially in this great project, from the founding donors to the solidarity initiatives by hundreds of families and associations.

Through the For the Brave initiative, we have managed to get to this point and we continue to work to cure more cases of childhood cancer that currently have no cure, improve treatments and minimise the sequelae that currently occur and reduce the emotional impact on children and families. In addition, our objective is to facilitate access to our center for children from developing countries, as well as to train professionals and cooperate with hospitals in those countries so that they can improve their patient care.


It is essential that the cases that arise are referred by the oncologist of each child in their country of origin. Knowledge of their previous treatment, as well as their evolution, is crucial for the best assessment in each case.
Andrés Morales, Healthcare Director of the Pediatric Oncology Department and the Neuro-Oncology Unit.
In Guatemala they no longer had any other treatment for Douglas and the tumour kept growing and expanding in his eye, but thanks to the generosity of many people, we are now here in Barcelona.
Katherin González. The mother of Douglas, the first patient treated through the PCCB Charity Fund

When they can't access the treatment needed in their country, we can help.

PCCB Charity Fund